Cargando…

Do serum prolactin levels correlate with antibodies against desmoglein in pemphigus vulgaris?

BACKGROUND: Pemphigus vulgaris is a chronic inflammatory disease of skin, the etiology of which is not completely known. Despite the latter, anti-desmoglein antibodies play a proven role in the pathogenesis. Recent studies showed an etiologic effect for prolactin in the pemphigus vulgaris. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iraji, Fariba, Tajmirriahi, Nabet, Momeni, Iman, Jamshidi, Kioumars, Hashemzehi, Fazlollah, Siadat, Amir Hossein, Esfahani, Alireza Asemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220690/ https://www.ncbi.nlm.nih.gov/pubmed/28217644 http://dx.doi.org/10.4103/2277-9175.191002

Ejemplares similares

Efficacy of adding topical simvastatin to topical calcipotriol on improvement of cutaneous plaque psoriasis
por: Iraji, Fariba, et al.
Publicado: (2014)

The efficacy of acyclovir in treatment of the pemphigus vulgaris
por: Iraji, Fariba, et al.
Publicado: (2013)

Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris
por: Amber, Kyle T., et al.
Publicado: (2018)

Salivary Desmoglein Enzyme-Linked Immunosorbent Assay for Diagnosis of Pemphigus Vulgaris: A Noninvasive Alternative Test to Serum Assessment
por: Mortazavi, Hossein, et al.
Publicado: (2015)

Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients
por: Saleh, Marwah Adly, et al.
Publicado: (2017)

Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris
por: Di Lullo, Giulia, et al.
Publicado: (2019)

Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous
por: Lucchese, Alberta, et al.
Publicado: (2006)

Long-lasting Localized Pemphigus Vulgaris without Detectable Serum Autoantibodies Against Desmoglein 3 and Desmoglein 1
por: Yoshifuku, Asuka, et al.
Publicado: (2016)

Pemphigus vegetans misdiagnosed as condylomata acuminata: A case report
por: Siadat, Amir Hossein, et al.
Publicado: (2022)

Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity
por: Delavarian, Zahra, et al.
Publicado: (2020)

Narrow-Band Ultraviolet B versus Oral Minocycline in Treatment of Unstable Vitiligo: A Prospective Comparative Trial
por: Siadat, Amir Hossein, et al.
Publicado: (2014)

Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes
Publicado: (1993)

An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris
por: Schulze, Katja, et al.
Publicado: (2011)

Improving Treatment Outcome of Pemphigus Vulgaris on Vietnamese Patients by Using Desmoglein Elisa Test
por: Van, Anh Tran Thi, et al.
Publicado: (2019)

Desmogleins 1, 3, and E-cadherin immunohistochemical expression within mucocutaneous pemphigus vulgaris
por: Alshami, Muhanad Lebnan, et al.
Publicado: (2022)

Targeted Disruption of the Pemphigus Vulgaris Antigen (Desmoglein 3) Gene in Mice Causes Loss of Keratinocyte Cell Adhesion with a Phenotype Similar to Pemphigus Vulgaris
por: Koch, Peter J., et al.
Publicado: (1997)

Pathogenic activity of circulating anti-desmoglein-3 autoantibodies isolated from pemphigus vulgaris patients
por: Narbutt, Joanna, et al.
Publicado: (2012)

HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies
por: Lakoš Jukić, Ines, et al.
Publicado: (2023)

Selective Elevation of Antibodies to Desmoglein 1 during the Transition from Mucocutaneous to Cutaneous Type Pemphigus Vulgaris
por: Matsuda-Hirose, Haruna, et al.
Publicado: (2013)

Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris
por: Schlögl, Elisabeth, et al.
Publicado: (2018)

A New Solid-Phase Immunosorbent for Selective Binding of Desmoglein 3 Autoantibodies in Patients with Pemphigus Vulgaris
por: Abramova, T. V., et al.
Publicado: (2020)

Plakophilins, desmogleins, and pemphigus: the tail wagging the dog
por: Ellebrecht, Christoph T., et al.
Publicado: (2014)

Autoantibodies against desmoglein 2 are not pathogenic in pemphigus()
por: Miguel, Marcela Calixto Brandão, et al.
Publicado: (2022)

Desmoglein compensation hypothesis fidelity assessment in Pemphigus
por: Sielski, Lauren, et al.
Publicado: (2022)

Multiple cutaneous and uterine leiomyomas
por: Asilian, Ali, et al.
Publicado: (2013)

Evaluation of prolactin levels in patients with newly diagnosed pemphigus vulgaris and its correlation with pemphigus disease area index
por: Lajevardi, Vahideh, et al.
Publicado: (2016)

A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
por: Lotti, Roberta, et al.
Publicado: (2023)

The efficacy of oral isotretinoin versus cyproterone compound in female patients with acne and the triad of cutaneous hyperandrogenism: A randomized clinical trial
por: Faghihi, Gita, et al.
Publicado: (2014)

Loss of flotillin expression results in weakened desmosomal adhesion and Pemphigus vulgaris-like localisation of desmoglein-3 in human keratinocytes
por: Völlner, Frauke, et al.
Publicado: (2016)

Anti-Thyroid Peroxidase Reactivity Is Heightened in Pemphigus Vulgaris and Is Driven by Human Leukocyte Antigen Status and the Absence of Desmoglein Reactivity
por: Seiffert-Sinha, Kristina, et al.
Publicado: (2018)

Generation of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for therapeutic application to squamous cell carcinoma
por: Funahashi, Shin-Ichi, et al.
Publicado: (2018)

Acantholysis may precede elevation of circulating anti‐desmoglein 3 antibody levels in pemphigus vulgaris presenting with desquamative gingivitis
por: Endo, Hiroyasu, et al.
Publicado: (2019)

Autoantibodies against Desmoglein 1 and 3 in South Tunisian pemphigus
por: Jerbi, Ameni, et al.
Publicado: (2021)

FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus
por: Maho-Vaillant, Maud, et al.
Publicado: (2022)

Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice
por: Hofrichter, Maxi, et al.
Publicado: (2018)

A Comparison of Betamethasone Valerate 0.1% Cream Twice Daily Plus Oral Simvastatin Versus Betamethasone Valerate 0.1% Cream Alone in the Treatment of Vitiligo Patients
por: Iraji, Fariba, et al.
Publicado: (2017)

Koebner phenomenon in pemphigus vulgaris patients
por: Balighi, Kamran, et al.
Publicado: (2016)

Serum Prolactin Levels in Psoriasis Vulgaris
por: Handjani, Farhad, et al.
Publicado: (2014)

Pemphigus vulgaris
por: Tamgadge, Sandhya, et al.
Publicado: (2011)

Pemphigus vulgaris
por: Porro, Adriana Maria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5fjkcr0cnf05c0g0s860e9uk3l